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We recently  reported  the  partial purification of a 
CAMP-independent and Ca2+-calmodulin-independent 
glycogen synthase kinase from porcine renal cortex 
(Schlender, K. K., Beebe, S .  J., and Reimann, E. M. 
(1981) Cold Spring  Harbor Conf. Cell Proliferation, 
389-400). Subsequent purification indicated that  the 
enzyme preparation consisted of at least three forms 
of glycogen synthase  kinase which  could be resolved 
by ATP gradient elution from aminoethylphosphate- 
agarose (AEP-agarose). The predominant form of gly- 
cogen synthase  kinase, which eluted from AEP-aga- 
rose between 2 and 6 m M  ATP, was purified approxi- 
mately 800-fold  and is designated GSK-A1. It had  a 
molecular weight of 45,000-50,000 as determined by 
gel filtration  and sucrose density gradient  centrifuga- 
tion. It catalyzed the  transfer of l mol of 32P/m~l of
synthase subunit into  a low molecular weight (10,000) 
CNBr peptide which was  tentatively identified as  Ser- 
7 (site 2) by high performance liquid chromatography, 
This phosphorylation decreased the  activity  ratio (ac- 
tivity in  the absence of glucose-6-P divided by activity 
in the presence of 7 . 2  mM glucose-6-P) from 0.95 to 
about 0.55. GSK-A1 appeared to be specific for and 
had low so.s values for both substrates, ATP (13 SM) 
and glycogen synthase (0.3-0.4 p ~ ) .  The enzyme could 
not use GTP as the phosphate donor. GSK-A1 was not 
affected by the protein kinase  inhibitor, CAMP, cGMP, 
Ca2+-calmodulin, EGTA, or trifluoperazine  and had a 
broad pH optimum (pH 7.0-8.5). A second form, GSK- 
A2, was eluted from AEP-agarose between 7 and 9 mM 
ATP. GSK-A2 could transfer  a  2nd mol  of “P/mol of 
synthase  subunit  and decreased the  activity  ratio  to 
0.30. The interrelation among these multiple forms is 
not clear, but the data suggest that multiple kinases 
are required to form the highly inactivated glycogen 
synthase  in  renal tissues. 
Glycogen synthase is the rate-limiting enzyme in glycogen 
synthesis (1). The complex control of the enzyme involves 
allosteric regulation as well as covalent modification via phos- 
phorylation-dephosphorylation which is under  hormonal  con- 
trol (2-4). Picton et al. ( 5 )  have identified seven phosphoryl- 
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ation  sites on synthase.  They have designated the  sites  as  la, 
lb, 2,  3a,  3b,  3c, and 5. They have further shown that  site 2 
is Ser-7 (5). As phosphate is added to  the various sites, less 
active forms of synthase  are produced with different kinetic 
parameters for the allosteric activator glucose-6-P and  the 
substrate UDPglucose (6). 
It is generally accepted that several well characterized ki- 
nases can phosphorylate and inactivate glycogen synthase. 
These include skeletal muscle CAMP-dependent protein ki- 
nase (7, 8) which is regulated by intracellular levels of CAMP 
and skeletal muscle phosphorylase kinase (9-12) which is 
regulated by eaz+  and calmodulin (13,14). Payne and Soder- 
ling (15) and Ahmad et al. (16) have shown that liver contains 
a CaZ+-calmodulin-dependent kinase that is distinct from 
phosphorylase kinase, and Woodgett et al. (17) have isolated 
a similar kinase from skeletal muscle. Recently, it  has become 
clear that a phosvitin/casein kinase is capable of catalyzing 
phosphorylation but  not inactivation of glycogen synthase. 
This kinase has been designated PCo.7 by DePaoli-Roach et 
al. (15, 19), casein kinase 2 by Huang et al. (20), and GSK-5 
by Cohen et al. (21). In addition, glycogen synthase is phos- 
phorylated by other cyclic nucleotide-independent and Cazc- 
calmodulin-independent glycogen synthase kinases whose 
regulatory mechanisms have not yet been elucidated (18, 21, 
22). 
Most of the work with glycogen synthase kinase has been 
done on enzymes purified from skeletal muscle. However, 
Schlender and Reimann (22) showed that among several rat 
tissues, kidney was the most abundant source of CAMP- 
independent glycogen synthase kinase. Little is known about 
the regulation of glycogen synthase in tissues such as the 
kidney with low concentrations of glycogen. The demonstra- 
tion that  the kidney cortical glycogen synthase activity ratio 
was low and  the Ao.s for glucose-6-P was high suggested that 
the  synthase  is highly phosphorylated (23). Given the predom- 
inance of CAMP-independent glycogen synthase kinase in 
this tissue (24) and  the absence of Ca2+-calmodulin-stimu- 
lated glycogen synthase kinase activity (23), it is highly likely 
that  the CAMP- and Ca2+-calmodu~in-independent glycogen 
synthase kinases are responsible for these  properties of renal 
cortical glycogen synthase. We recently reported on the  par- 
tial purification of GSK-P’ from porcine renal cortex (23), 
The abbreviations used are: GSK-P, forms of glycogen synthase 
kinase which  bind to phosphocellulose and elute at 0.5 M NaCI; GSK- 
0, forms ofglycogen synthase kinase which bind to DEAE-cellulose 
but  do  not  bind to phosphocellulose; AEP-agarose, aminoethylphos- 
phate-agarose; SDS-PAGE, polyacrylamide gel electrophoresis in the 
presence of sodium dodecyl sulfate; PMSF, phenylmethylsulfonyl 
fluoride; GSK-A1, form of  glycogen synthase kinase eluted from AEP- 
agarose by 2-6 mM ATP; GSK-A2, form of glycogen synthase kinase 
eluted from AEP-agarose by 7-9 mM ATP; EGTA, ethylene glycol 
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We now report  that a  recently developed agarose resin  con- 
taining  an  aminoethylphosphate group can be  used to  isolate 
multiple  forms of glycogen synthase  kinase which are  present 
in porcine renal cortex. At least three forms of glycogen 
synthase  kinase were separated by ATP gradient  elution of 
glycogen synthase  kinase  from AEP-agarose. The major form 
of glycogen synthase designated GSK-A1 was purified and 
characterized. 
EXPERIMENTAL  PROCEDURES 
Materials-Rabbit skeletal muscle glycogen synthase was prepared 
through the polyethylene glycol precipitation step followed by phos- 
phocellulose chromatography (glycogen-free) or through the ethanol 
precipitation step (glycogen-bound) as previously described (25). The 
inhibitor of the CAMP-dependent protein kinase (26) and catalytic 
subunit of cyclic AMP-dependent protein kinase (27)  were prepared 
as previously described. Phosphorylase b was prepared from rabbit 
skeletal muscle by the method of Fischer and Krebs (28). Phospho- 
rylase kinase was prepared from rabbit skeletal muscle through the 
Sepharose 4B gel filtration step (29) or was a gift from Dr. Ted 
Chrisman (Howard Hughes Medical Institute,  Department of Physi- 
ology, Vanderbilt School of Medicine). [Y-~'P]ATP was prepared 
according to  the method of Walseth and Johnson (30). Dr. Simon 
Pilkis (Department of Physiology, Vanderbilt School of Medicine) 
kindly provided the following: 6-phosphofructo-l-kinase, 6-phospho- 
fructo-2-kinase, and fructose 2,6-bisphosphate. Dr. Jackie Corbin 
(Howard Hughes Medical Institute, and Department of Physiology, 
Vanderbilt School of Medicine) generously provided beef lung cGMP- 
dependent protein kinase, rabbit skeletal muscle type I, and beef 
heart type I1 regulatory subunit of cyclic AMP-dependent protein 
kinase. Immersible Cx ultrafilters were purchased from the Millipore 
Corp. AEP-agarose was a product from Pierce Chemical Co.  All other 
chemicals and reagents were obtained from sources previously indi- 
cated (25). 
Swine kidneys were obtained from the local slaughterhouse. Ap- 
proximately 15-30 min after the animals were killed, the kidneys 
were placed on ice and transported to  the laboratory for dissection to 
remove the cortex. In some experiments fresh cortex was used and in 
others the tissue was stored at  -70 "C for up to 4 weeks before 
isolation of  glycogen synthase kinase. When the cortex was stored at 
-70 "C for longer periods of time, the recovery of  glycogen synthase 
kinase in the first  and/or second chromatography steps was signifi- 
cantly reduced. 
Glycogen Synthase Kinase Assays-Unless otherwise indicated, 
glycogen synthase kinase activity was determined by measuring the 
inactivation of rabbit  skeletal muscle glycogen synthase  as previously 
described (25) with the following changes. The buffer was 35 mM 
Tris-HC1 (pH 7.8 a t  25 "C), and  the reaction mixture contained 1 mM 
ATP, 2 mM Mg(Ac),, 0 or 4 mM NaCl, and 0 or  0.002% Brij 35.  An 
inactivation unit of glycogen synthase kinase activity is defined as 
the amount of enzyme which causes the glycogen synthase activity 
measured in the absence of glucose-6-P (31) to decrease by 1 milliunit/ 
min at 30  "C. Phosphorylation by kinases did not change the activity 
measured in the presence of glucose-6-P. Kinase activity was linear 
with time and dilution over a very narrow range, but resonable 
estimates of activity could be obtained when the activity ratio (activ- 
ity in the absence of glucose-6-P divided by activity in the presence 
of 7.2 mM glucose-6-P) was reduced from the initial value of 1.0 to 
between 0.95 and 0.75. 
out  as previously described (25) with the following exceptions. The 
Phosphorylation and inactivation of  glycogen synthase was carried 
reaction mixture included 50 mM Tris-HC1 (pH 7.8 at 25 -C), 1.9 or 
9 mM P-glycerol phosphate, and 0 or 4 mg  of glycogen/ml. At  various 
time points, aliquots were  removed and analyzed for protein-bound 
32P or activity ratio. One  glycogen synthase kinase phosphorylation 
unit  is equal to 1 pmol of 32P incorporated into glycogen synthase/ 
min. 
Purification of  Glycogen Synthase Kinase from Porcine Renal Cor- 
tex-A procedure was  developed to purify the major glycogen synthase 
kinase from porcine renal cortex. Frozen cortex (250  g)  was thawed 
Waring blender with 625  ml of 8 mM K2HP04, 2 mM KHzPOI, 1 mM 
for 15 min in cold running tap water and then homogenized in a 
EDTA, 0.5 mM PMSF, and 250 mM sucrose (pH 7.8).  All operations 
were carried out  at 0-4 "C unless otherwise stated. The homogenate 
was centrifuged for 50 min a t  30,000 X g. The  supernatant was filtered 
through glass wool. The clear extract was added to 190 ml of phos- 
phocellulose which had been equilibrated in homogenizing buffer. 
After 1 h the suspension was filtered on  a funnel equipped with a 
porous polyethylene plate, washed with 1 liter of homogenizing buffer, 
and  then washed with 1 liter of homogenizing buffer (containing 150 
mM NaC1) without sucrose. The resin was then suspended in the 
latter buffer, poured into a 5-cm diameter column, and washed with 
an additional bed volume of buffer containing 150 mM NaC1. The 
GSK-P was eluted with buffer containing 8 mM K2HP04, 2 mM 
KH2P04, 1 mM EDTA, 0.5 mM PMSF, and 500 mM NaCl (pH 7.3). 
In a series of nine batch adsorptions carried out in this manner, 
recoveries of GSK-P in the 500 mM NaCl eluates were 42.2 ? 3.3% 
(mean f S.E.) and  the fold purification was  16.5 f 3 (mean ? S.E.). 
No additional activity was detected by the glycogen synthase kinase 
assay when the column was  washed with 1 M NaCl, but activity could 
be detected by measuring 32P incorporation into glycogen synthase. 
The phosphocellulose eluate (GSK-P) was diluted 3-fold with 5 
mM K2HP04, 5 mM KH2P04, 1 mM EDTA, 0.5 mM PMSF  (pH 6.9), 
and applied to a hydroxyapatite column (2.6 X 11.3 cm) equilibrated 
in the above buffer containing 150 mM NaC1. After the sample was 
applied, the column was washed with the following sequence of 
buffers: 1) 3 bed volumes of 6 mM KzHP04, 4 mM KHzP04, 1 mM 
EDTA, 0.5 mM PMSF (Buffer A, pH 7.1) containing in addition 500 
mM NaCl; 2) 2 bed volumes of Buffer A and 3) 3 bed volumes of 
Buffer A containing 15 mM potassium citrate.  These washes eluted 
little or no glycogen synthase kinase activity. Glycogen synthase 
kinase was then eluted with Buffer A containing 15 mM potassium 
citrate  and 350 mM NaC1. 
The hydroxyapatite eluate (15.5 ml) was then adjusted to pH 7.8 
at  1 "C with 45 ml of 10 mM K2HP04, 1 mM EDTA, and 0.01% Brij 
35. The preparation was then adjusted to a final volume of 230 ml 
with 8 mM KzHPO,, 2 mM KHzP04, 1 mM EDTA, 0.01% Brij 35 (pH 
7.8). This diluted the NaCl in the hydroxyapatite eluate to about 20 
mM. The inclusion of the detergent Brij 35 aided in the stability of 
glycogen synthase kinase under these conditions of high dilution. 
Dialysis to remove salt often resulted in greater losses of activity 
than when the preparation was diluted in the presence of Brij 35. 
The entire volume  was applied to  an AEP-agarose column (0.9 X 12 
cm) equilibrated in 8 mM K2HPO4,2 mM KH2PO4, and 0.01% Brij 35 
(pH 7.8). After the sample had been applied, the column was washed 
with 2 bed  volumes of equilibrating buffer. The column was eluted 
with a linear gradient of  0-15 mM ATP in equilibrating buffer 
adjusted to pH 7.8 (total volume 60 ml). The AEP-agarose column 
resolved  glycogen synthase kinase activity into two components des- 
ignated GSK-A1, eluting between 2 and 6 mM ATP,  and GSK-A2, 
eluting between 7  and  9 mM ATP (Fig. lA). Fractions were  pooled as 
indicated in  Fig. lA and concentrated using an immersible Millipore 
filter. No additional activity could be eluted by washing the column 
with buffer containing 500 mM NaCl. 
In addition to  the forms of glycogen synthase kinase that were 
bound (Fig. lA), about 10% of the glycogen synthase kinase activity 
was not bound to  the column under these conditions. When the flow- 
through fractions from the first AEP-agarose column were rechro- 
matographed on a second AEP-agarose column, all the glycogen 
synthase kinase was bound to  the column (Fig. 1B). When the column 
was eluted with an ATP gradient, at least three peaks were  resolved. 
Two small peaks of activity eluted below 2 mM ATP, and a third 
major peak of activity eluted between 2 and 6 mM ATP. The  latter 
presumably represents GSK-A1 which  was  overloaded on the primary 
column. 
The pooled and concentrated GSK-A1 and GSK-A2 were sepa- 
rately chromatographed on a Sephadex G-150 fine column (1.5 X 86 
cm) (Fig. 2). Both of the glycogen synthase kinase preparations eluted 
as single peaks with apparent molecular weights  of about 45,000. A 
protein peak preceded the glycogen synthase kinase activity of GSK- 
A1 (Fig. 2 A ) .  When individual fractions were separately subjected to 
SDS-PAGE, the protein peak which preceded the glycogen synthase 
kinase activity appeared as  a band near 30,000 daltons (not shown). 
To minimize contaminatingprotein, only fractions 48-54  were pooled. 
The pool was concentrated 6-fold using the immersible Millipore 
filter. On SDS-PAGE this preparation still contained the 30,000- 
dalton  protein in addition to a  prominent band at 45,000 and three 
minor bands between 30,000 and 45,000. Fractions 42-51 from the 
second Sephadex G-150 column were  pooled for GSK-A2 (Fig. 2B). 
The pooled fractions were concentrated 8.5-fold with the immersible 
Millipore filter. A summary of the purification is presented in Table 
I. 
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FIG. 1. Aminoethylphosphate-agarose chromatography. A, 
chromatography was carried out  as described in the text. The proteins 
were eluted with a linear ATP gradient. At  an elution volume of  330 
ml, the column was washed with 8 mM K2HP04, 1 mM EDTA, 0.01% 
Brij 35, 500 mM NaCl. B, rechromatography of AEP-agarose flow- 
through fractions. The flow-through fractions were pooled and re- 
chromatographed on the same AEP-agarose column (1.6 x 2.5 cm). 
The proteins were eluted with a 60-ml linear gradient between 0 and 
12 mM ATP.  Fractions (0.85  ml)  were assayed for glycogen synthase 
kinase activity (e), ATP (a), and protein (A). 
using standard proteins. The proteins,  their molecular weights, and 
their Stokes radii in nanometers were: blue dextran (void volume 
marker); bovine serum albumin (67,000,3.6); ovalbumin (45,000,2.7); 
catalytic subunit of CAMP-dependent protein kinase (40,000, 2.7); 
carbonic anhydrase (30,000, 2.3); chymotrypsinogen A (25,000, 2.41, 
and adenosine (inclusion volume marker). 
Sucrose Density Gradient Centrifugation-Sucrose gradients were 
done by modification of the method described by Brandt et al. (32). 
Glycogen synthase kinase was applied to the top of a 5-25% sucrose 
gradient in 6 mM K,HPO,, 4 mM KH2P04,  and 1 mM EDTA (pH 
7.1). Catalase (10 mg/ml, s20,w = 11.1) was included as an internal 
standard, and catalase and lactoperoxidase (10 mg/ml, ~ 2 0 , ~  = 5.4) 
were applied to a  separate gradient as external  standards. Centrifu- 
gation was for 16 h at  40,000 rpm in an SW 50.1 rotor in  a Beckman 
L2-65B ultracentrifuge at 4 "C. The molecular weight and frictional 
ratio were calculated as described by  Siege1 and Monty (33). 
Polyacrylamide Gel Electrophoresis-Ten or  7.5% slab SDS-PAGE 
was carried out  as described by Laemmli (34). Gels were stained with 
0.12% Coomassie brilliant blue A-250 in 7.5% acetic acid and 50% 
(v/v) methanol. 
High Performance Liquid Chromatography-Reverse phase high 
performance liquid chromatography of tryptic peptides derived from 
phosphorylated glycogen synthase was done in collaboration with Dr. 
Thomas R. Soderling (Howard Hughes Medical Institute, Depart- 
ment of Physiology, Vanderbilt School of Medicine). This procedure 
will separate phosphorylation sites la,  lb, 2, 3abc, and 5 (35). 
Other Methods-Proteins were determined by the Lowry method 
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FIG. 2. Sephadex G-150 gel filtration of GSK-A1 and GSK- 
A2. A, concentrated GSK-A1 from an AEP-agarose column was 
applied to a Sephadex G-150 column equilibrated in  6 mM K2HP04, 
4 mM KH~POI, 1 mM EDTA, 200 mM NaCl, and 0.01% Brij 35. 
Fractions between  48 and 54  were  pooled and concentrated by Milli- 
pore filtration. B, concentrated GSK-A2 from an AEP-agarose col- 
umn was applied to a Sephadex G-150 column as described above. 
Fractions between 42 and 51 were  pooled and concentrated by Milli- 
pore filtration.  Fractions were assayed for glycogen synthase kinase 
activity (e) and protein (A). The arrows indicate the elution volume 
of ovalbumin. 
TABLE I 
Purification of porcine renal cortical glycogen synthase k i m e  
Details of the purification procedure were as described in the text. 
Assay of  glycogen synthase kinase was by inactivation of glycogen- 
bound synthase.  Proteins were determined by the method of Hartree 
(36). AEP-agarose 1 and AEP-agarose 2 represent AEP-agarose 





AEP-agarose 1 (concen- 
trated) 
Sephadex G-150 1 (con- 
centrated) (GSK-A1) 
AEP-agarose 2 (con- 
centrated) 
Sephadex G-150 2 (con- 
centrated) (GSK-A2) 
mg 
100  25.8 325,860 12,615 
% 
16 1,768  51,130 28.9 
39 321 126,620 395 
11.5 8,970 780  2.8 
0.16 3,213 
0.2 4,787 772  0.16 
0.3 355 1,000 2.8 
1.0 19,631 













method of Bradford (37). Kinetic parameters were calculated by 
nonlinear regression analysis (38). 
RESULTS 
Multiple Forms of Glycogen Synthase Kinase from  Porcine 
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described above, on Sephadex G-100 revealed several molec- 
ular weight forms of glycogen synthase kinase with activity 
insensitive to CAMP, Ca*’-calmodulin, or the heat-stable 
inhibitor of CAMP-dependent protein  kinase (data  not 
shown). Compiling data from several experiments demon- 
strated a major glycogen synthase kinase activity peak eluting 
with an  apparent molecular weight of 45,000-50,000. In  ad- 
dition there was a prominent shoulder of activity eluting at 
50,000-55,000. A small peak of activity  eluted at  >70,000, and 
in some experiments  activity  eluted with an  apparent molec- 
ular weight of 35,000. The appearance of multiple peaks of 
glycogen synthase kinase activity on Sephadex G-100 was 
unaffected by the presence of protease inhibitors (PMSF, 
benzamidine, and  EDTA). Similar gel filtration profiles were 
obtained  under  a variety of conditions including the use of 
fresh or frozen tissue, homogenization with or without sucrose 
present, or when 50 mM Tris, 200 mM NaCl (pH 7.5), or 10 
mM potassium phosphate, 200 mM Naci  (pH 7.2), or 100 mM 
phosphate (pH 7.2) buffer systems were  used. When gel 
filtration column fractions were assayed for inhibitor-sensi- 
tive histone kinase activity, nearly all of the activity was 
CAMP-dependent and appeared  in the void volume, indicating 
that  the CAMP-dependent protein kinase chromatographed 
as  the holoenzyme with little, if any, free catalytic subunit 
present. 
Previous studies  had shown that glycogen synthase kinase 
of rabbit kidney extracts could be separated into two types 
(GSK-D and  GSK-P) by chromatography on phosphocellu- 
lose and DEAE-cellulose (24). As measured by the synthase 
inactivation assay, about 25% of the glycogen synthase kinase 
activity in swine renal cortex was GSK-D and 75% was GSK- 
P. GSK-D and GSK-P eluted from Sephadex G-100 with 
apparent molecular weights of 50,000-55,000 and 45,000- 
50,000, respectively. Using the synthase phosphorylation as- 
say, a small amount of a third type of glycogen synthase 
kinase could be detected. The  latter, which was eluted from 
phosphocellulose by about 1 M NaCl, also contained  heparin- 
sensitive casein kinase activity and is likely similar to the 
enzyme purified from rabbit  skeletal muscle designated PCQ.7 
(18,19), casein kinase 2 (20), or  GSK-5 (21). 
Purification of  Glycogen Synthase Kinases-The major form 
of  glycogen synthase kinase, designated GSK-A1, was purified 
from porcine renal cortex as described under  “Experimental 
Procedures.” GSK-A1 was purified approximately 1000-fold 
with recoveries of 1-3% of the glycogen synthase kinase 
activity of the initial extract. A second glycogen synthase 
kinase, designated GSK-A2, was purified to a lesser extent 
(Table I). These enzymes were used for the studies described 
below. 
Sedimentation Coefficient, Stokes Radius, and Molecular 
Weight of GSK-Al-Sucrose density  gradients were carried 
out on glycogen synthase kinase after purification through 
the Millipore filter concentration of the hydroxyapatite  eluate 
as described under “Experimental Procedures.” The sedimen- 
tation coefficient was calculated to be 4.0. The peak widths 
of the  standards  and glycogen synthase  kinase activity were 
essentially the same. Since the hydroxyapatite eluate con- 
tained  both  GSK-A1 and GSK-AB, these  results  indicate that 
these two forms have similar  sedimentation coefficients. 
The Stokes  radius of GSK-A1 was determined  on  a cali- 
brated Sephadex G-150 column in  the presence of 0.01% Brij 
35. The detergent was included to stabilize the enzyme and 
was also present  during the calibration of the column with 
protein  standards. The Stokes  radius was determined to be 
2.85 nm (Table 11). This value was not significantly different 
from the value of 2.95 nm obtained for the partially purified 
TABLE I1 
Properties of GSK-A1 
Gel filtration and sucrose density gradient centrifugation were 
carried out as described  under “Experimental Procedure” and in the 
text. pH studies are  described in the text. 
Property 
Stokes radius (nm) 2.85 
S Z 0 , W  4.00 
Molecular weight 
Gel filtration 45,000 
Calculated 48,000 
Frictional ratio 1.20 
pH  optimum 7.0-8.5 
TABLE 111 
Protein substrate  specificity of GSK-A1 
The reaction was carried out as described under “Experimental 
Procedures” for the phosphorylation of glycogen synthase except the 
substrate was  varied. Each substrate was at 0.1 mg/ml. Tris-HC1  was 
50 mM and @-glycerol phosphate was 9 mM. The 32P-protein was 
isolated on Whatman ET-31 cellulose filter papers as previously 
described (25). Time courses were run in duplicate, and the rates 
were determined by regression analysis. The data are expressed as 









Glycogen synthase kinase 
A1 activity 
pmol/min/pg 
76 f 2.6 
79 * 5.7 
0.1 f 0.5 
3.6 +- 3.5 
0.8 f 0.6 
4.9 rt- 1.3 
0.0 f 2.1 
enzyme chromatographed on a Sephadex G-100 column in  the 
absence of the detergent  Brij 35 (23). When the value of 2.85 
nm for  Stokes  radius and  the sedimentation coefficient of 4.0 
were used, the calculated molecular weight was 48,000 for 
GSK-A1  (Table 11). This value is in good agreement with the 
apparent molecular weights of 45,000 for GSK-A1 determined 
from the calibrated Sephadex G-150 chromatography (Table 
11) and  the prominent band obtained  on  SDS-PAGE (45,000). 
Effect of pH on Activity of GSK-AI-The effect of pH  on 
GSK-A1 activity was determined with MES buffer between 
pH 5.5 and 7.0 and Tris buffer between 7.0 and 8.5. The 
enzyme had  a broad pH optimum with essentially the same 
activity between pH 7.0 and 8.5. There was a marked decrease 
in  activity as  the pH was decreased from pH 7.0 to 5.5. 
Nucleotide Substrate Specificity of GSK-At-Since some of 
the glycogen synthase kinases purified from other laboratories 
have been reported to use GTP (19-21) and  dATP (25) as 
phosphoryl donors, it was  of interest to determine the nucleo- 
tide specificity of GSK-A1. GSK-A1 inactivated glycogen 
synthase most effectively when 1 mM ATP was the phosphate 
donor. dATP was only about 15% as effective as ATP. GSK- 
A1 could not use 1 mM GTP,  CTP,  ITP, or UTP  in place of 
ATP. 
Protein  Substrate Specificity of GSK-At-Table 111 shows 
the protein substrate specificity of GSK-AI.  Both glycogen- 
free and glycogen-bound glycogen synthase served equally 
well as substrates.  GSK-A1 was unable to catalyze the phos- 
phorylation of phosphorylase kinase when the  substrate con- 
centration was  0.1 (Table 111) or 0.4 mg/ml (data not shown) 
or phosphorylase when the concentration was 0.1 (Table Iv) 
or 19 mg/ml (data  not shown).  Histone, casein, and phosvitin 
have often been used to follow the purification of glycogen 
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GSK-A1  (Table 111). GSK-A1 was unable to phosphorylate 
cGMP-dependent  protein kinase, type I1 regulatory subunit, 
type I regulatory subunit of CAMP-dependent protein kinase 
(data  not  shown).  In  addition,  GSK-A1 was unable to  incor- 
porate phosphate into 6-phosphofructo-1-kinase or 6-phos- 
phofructo-2-kinase  (data  not shown). Therefore, GSK-M  ap- 
pears  to be highly specific for glycogen synthase. 
Potential Modifiers of GSK-A1 Activity-Several potential 
modifiers of GSK-A1  activity were tested.  NaCl was found to 
be inhibitory  and  it was, therefore, important  to remove salt 
before assaying glycogen synthase kinase fractions. 64 mM 
NaCl  caused  approximately  50% inhibition of GSK-A1. Other 
inhibitors of GSK-A1  activity included 1 mM Na2S04  (55%), 
0.5 mM UDP (30%), 0.5 mM UDP-glucose (35%), 0.5 mM 
ADP (62%), and 50 mM KF, the most effective inhibitor 
(95%). The sugar phosphates glucose-6-P, glucosamine 6- 
phosphate,  and glucose-1-P (0.5 mM each)  had no effect on 
GSK-A1 activity. Glycogen synthase kinase  activity was not 
affected by 1 mM fructose  2,6-bisphosphate,  2 mM EGTA, 0.2 
mM Ca2+ and 0.4 FM calmodulin,  5 p M  CAMP, 5 Fm cGMP, 
80 p~ trifluoperazine, or 5 pg of phosphatidylserine/ml in  the 
presence of 0.2 mM Ca2+  and 0.4 WM calmodulin. 
Kinetic Parameters of GSK-AI-The s0.5 values for glycogen 
synthase  and  ATP were determined for GSK-A1. The kinetics 
for glycogen synthase were determined using the following as 
substrates:  1) glycogen-bound synthase; 2) glycogen-free syn- 
thase  with 4 mg of glycogen/ml present; and 3) glycogen-free 
synthase. Assuming a tetrameric  structure for glycogen syn- 
thase,  the K,,, values for GSK-A1 were 0.26, 0.46, and 0.33 
PM, respectively. The Hill  coefficients were not  different from 
1.0. The presence of glycogen had very little effect on the 
V,,,. The K,,, value  using ATP as the variable substrate was 
determined  to be 13.1 FM. 
Phosphorylation and Inactivation of Glycogen Synthase by 
GSK-A1 and GSK-P-Phosphorylation and inactivation of 
glycogen synthase by several concentrations of GSK-A1  and 
GSK-P  are shown in Figs. 3 and 4, respectively. Little if any 
change  in  the  activity  ratio was seen  in the control experi- 
ment. When 70 phosphorylation units of GSK-Al/ml were 
present,  phosphate  incorporation reached  a  maximum of 0.5 
mol of 32P/mol of synthase  subunit  and did not change over 
the next 90 min of incubation (Fig. 3, upper). The activity 
ratio was reduced to about 0.75 (Fig. 3, lower). When the 
concentration of GSK-AI (in unitslml) was 835, 1670 (Fig. 
3), or 3000 (not  shown), most of the reaction was completed 
within 3 min and  after 2  h of incubation no  more than 1 mol 
of "P/mol of synthase subunit was incorporated and the 
activity ratio was reduced to  about 0.5. 
Fig. 4 shows the same type of experiment with GSK-P. 
Forty  phosphorylation  units of GSK-P/ml catalyzed the  in- 
corporation of nearly 1 mol of 32P/mol of synthase  subunit  in 
60 min. When 1050 units of GSK-P/ml were incubated with 
synthase, nearly 2.5 mol of 32P/mol of synthase  subunit were 
incorporated  and  the  activity  ratio was reduced to less than 
0.20. A  similar concentration of GSK-A1 (835 units/ml)  cat- 
alyzed incorporation of only 1 mol of 32P/mol of synthase 
subunit  and reduced the  activity  ratio  to 0.50-0.60 (Fig. 3). 
The correlation of phosphorylation with activity ratio for 
GSK-A1 and GSK-P is illustrated in Fig. 5. GSK-A2 (600 
units/ml) catalyzed phosphorylation of synthase  to  the level 
of 1.7 mol of 32P/mol of synthase  subunit  and reduced the 
activity ratio to 0.3 (data  not shown). Thus,  it  appears  that 
kinases  in  GSK-P resolved by  AEP-agarose  chromatography 
have different specificities  with  respect to  the phosphoryla- 
tion  sites  on glycogen synthase. 
Glycogen Synthase Phosphorylation Site Specificity-Gly- 
2 2 
d I $: 0 
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Tim. (mlnutor) 








FIG. 3. Time courses for the phosphorylation (upper) and 
inactivation (lower) of  glycogen-bound glycogen synthase by 
GSK-At. GSK-A1 was added to yield a  final concentration of 0 (0), 
70 (a), 835 (U), and 1670 (A) phosphorylation units/ml. Phosphoryl- 
ation obtained in the absence of any added GSK-A1 was substracted 
to give net phosphorylation in the presence of kinase. 
c"" 
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FIG. 4. Time courses for the phosphorylation (upper) and 
inactivation (lower) of  glycogen-bound glycogen synthase by 
GSK-P. GSK-P was added to yield a final concentration of 0 (0), 40 
(a), 210 (O), and 1050 (A) phosphorylation units/ml. In  the presence 
of GSK-P, net phosphorylation is presented. 
cogen synthase  can be phosphorylated at multiple  sites.  Sev- 
eral approaches to the localization of the phosphorylation 
sites on the synthase molecule were attempted. The first 
approach used trypsin  to partially digest the 32P-labeled  syn- 
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and inactivation catalyzed by GSK-A1 (A) and GSK-P (B) .  
FIG. 5. Correlation of glycogen synthase phosphorylation 
The activity ratio was plotted as a function of the phosphorylation 
state using data obtained from experiments as described in Figs. 3 
and 4. 
.TABLE IV 
Distribution of phosphate between trypsin-sensitive and trypsin- 
insensitive regions of glycogen synthase 
32P-IabeIed giycogen synthase (glycogen-bound) was prepared to 
various  degrees  of phosphorylation with GSK-A1, GSK-P,  or catalytic 
subunit of CAMP-dependent protein kinase. The determination of 
trypsin-sensitive and trypsin-insensitive regions of 32P-labeled gly- 
cogen synthase was determined as previously  described (40). The data 




0.22 f 0.01 
96 0.74 f 0.00 0.03 f 0.05  0.77 f 0.05 
111 0.42 f 0.02 -0.04 f 0.03 0.38 f 0.01 
95 0.21 f 0.01 0.01 f 0.01 
0.33 f 0.01  -0.01 f 0.06 0.34 f 0.04 103 
1.26 f 0.07 112 1.41 k 0.03  -0.15 f 0.03 
1.88 f 0.01 90 1.70 * 0.06 0.18 f 0.05 
CAMP-dependent 15 0.1 f 0.03 0.58 -t 0.08 0.68 -C 0.05 
protein kinase 
are generated. These  can be differentiated by their solubility 
in trichloroacetic acid (39) (Table IV). When synthase was 
phosphorylated to a level of 0.7 mol of 32P/mol of synthase 
subunit by GSK-AI, essentially all of the phosphate was 
incorporated in the trypsin-insensitive site (trichloroacetic 
acid-insoluble). Likewise, when GSK-P catalyzed the  transfer 
of 0.3,  1.3, or 1.9 mol of 32P/mol of synthase subunit, by and 
large all of the 32P was associated with trypsin-insensitive 
sites. Since GSK-P contains  a  mixture of kinases, it appeared 
that all of these forms had  a high specificity for the  trypsin- 
insensitive phosphorylation domains. In contrast, the first 
phosphate  incorporated into  synthase by the catalytic subunit 
Synthase Kinase 
a 
t t I  t t  
b c  d e  10- 
8-  
8 6- 
: 4 -  
n 
c 
0 0.2 0.4 0.6 0.8 1.0 
Relative Mobility 
FIG. 6. SDS-PAGE of CNBr-cleaved s2P-labeled glycogen 
synthase. The glycogen synthase was phosphorylated to a level of 
0.8 ml of 32P/mol of synthase subunit. After CNBr cleavage, as 
described by Soderling et al. (40), the sample was  subjected to SDS- 
PAGE as described  under "Experimental Procedures." The gels were 
exposed to film and the resulting autoradiogram  was scanned on a 
densitometer. The protein standards and molecular weights include: 
a, chymotrypsinogen (25,700); b, lysozyme (13,300); c, bovine trypsin 
inhibitor (6,000); d, insulin (3,000), and e, the dye front. 
of CAMP-dependent protein kinase was found to be in the 
trypsin-sensitive domain (Table IV). 
A second approach was to use CNBr to cleave the 32P- 
labeled synthase molecule (40). Synthase was phosphorylated 
to  the level of 0.80 mol of 32P/mol of a  subunit with GSK-A1. 
After cleavage with CNBr,  the synthase was then electropho- 
resed on SDS-PAGE. The gels  were then exposed to film and 
the resulting autoradiogram was scanned  on  a densitometer 
(Fig. 6). The scan indicated that  the major phosphorylated 
site was on a low molecular weight peptide (approximately 
10,000). Cohen et al. (21) have recently shown that when 32P- 
labeled glycogen synthase is digested by low concentrations 
of trypsin,  sites 2,3a, 3b, and 3c are  in the trypsin-insensitive 
domain. In addition, Cohen et al. indicated that the low 
molecular weight CNBr peptide contained only site 2 (Le. 
Ser-7). Consequently, since the GSK-A1 synthase phospho- 
rylation site is trypsin-insensitive and on a low molecular 
weight CNBr peptide, it appears that GSK-A1 phosphorylates 
site 2. This was confirmed by the use of reverse phase high 
performance liquid chromatography of tryptic digests. When 
GSK-A1 incorporated 0.80 mol of 32P/mol of synthase  sub- 
unit, 95% of the label eluted  in  a position corresponding to 
site 2 (Fig. 7). The small peak eluting near 115 min and 
preceding the major peak appears to be a breakdown product 
of site 2.2 
To further establish that Ser-7 was the site phosphorylated 
by GSK-A1, glycogen synthase was phosphorylated by GSK- 
A1 to  the  extent of 0.7 mol of 32P/mol of subunit. The 32P- 
synthase was then incubated under standard phosphorylation 
conditions with phosphorylase kinase, an enzyme specific for 
Ser-7 (21). Aliquots were  removed at 15, 30, and 45 min and 
32P bound to synthase was determined. There was no addi- 
tional phosphorylation of synthase by the added phosphoryl- 
ase kinase (data not shown). When glycogen synthase was 
incubated in an identical manner except GSK-A1 was not 
added, subsequent addition of phosphorylase kinase resulted 
in  the incorporation of 0.4 mol  of 32P/mol of synthase  subunit 
within  15 min. Phosphorylation of  glycogen synthase byphos- 
phorylase kinase leveled off at  about 0.5 mol of 32P/mol of 
subunit. Conversely, if glycogen synthase was first phospho- 
rylated by phosphorylase kinase and then incubated with 
GSK-A1, little additional phosphate was incorporated into 
synthase. 






















6 0 -  
z 
I 5 0 -  n 
0 
n 







0 20 40 60 80 100 120 l d  
TIME (minutes) 
h 
FIG. 7. Reverse phase high performance liquid chromatog- 
raphy of 3aP-labeled glycogen synthase tryptic peptides. The 
procedure was carried out according to  the method of Juhl et al. (35). 
Glycogen synthase was phosphorylated to a level of 0.7 mol of 32P/ 
mol of synthase subunit with GSK-A1 and  then precipitated with 
10% trichloroacetic acid. The precipitate was washed twice with ether 
and taken up in 100 mM ammonium bicarbonate (pH 8.0) and  then 
digested with 1 mg/ml of trypsin for 5 h. The digest was then 
chromatographed on  a Beckman 421 high performance liquid chro- 
matograph using an acetonitrile gradient in 0.1% trifluoroacetic acid 
on a Beckman c-18 Ultrasphere ODS column (0.46 X 25 cm).  The 
gradient flow rate was 1 ml/min as follows: 0.5% acetonitrile for 10 
min, 5-38% for 100 min, and 38-50% for 5 rnin. Two-ml fractions 
were collected. 32P was determined by Cerenkov's counting. The 
arrows indicate the elution positions: a, site la; b, site 5; c, sites 3abc; 
d, site lb; e, site 2. 
DISCUSSION 
Multiple forms of CAMP- and Ca"-calmodulin-independ- 
ent glycogen synthase kinases have been previously demon- 
strated in rabbit skeletal muscle (18, 21, 41), rat skeletal 
muscle (25), and several other  rat tissues (22). Schlender and 
Reimann (22, 24) subdivided glycogen synthase kinases into 
forms that bind to phosphocellulose (GSK-P)  and forms that 
bind to DEAE-cellulose (GSK-D).  Schlender et al. (25) used 
Sephadex G-100 to separate two forms of GSK-P from rabbit 
skeletal muscle. DePaoli-Roach et al. (18) further subdivided 
synthase kinases into forms that elute from phosphocellulose 
a t  low ionic strength  (PC,,  and PCo,) and forms that elute a t  
high ionic strength (PC,,). Cohen et al. (21), using a procedure 
similar to  that of DePaoli-Roach et al. (18), have recently 
separated three  distinct glycogen synthase kinases designated 
GSK-3, GSK-4, and GSK-5. The  latter kinase appears to be 
the phosvitin/casein kinase designated PCo.7 by DePaoli- 
Roach et al. (18, 19) or casein kinase 2 by Huang et al. (20). 
This kinase differs from the  other glycogen synthase kinases 
studied in that it phosphorylates but does not inactivate 
glycogen synthase. 
Several lines of evidence are  presented here which demon- 
strate  that porcine renal cortex contains multiple forms of 
cyclic nucleotide- and Ca2+-calmodulin-independent glycogen 
synthase kinases. The major glycogen synthase kinase forms 
in crude extracts were bound to phosphocellulose and eluted 
at  low ionic strength  (GSK-P), while a lesser form, GSK-D, 
failed to bind to  the phosphocellulose. Since GSK-D appeared 
to be slightly larger than  GSK-P (50,000-55,000 Versus 
45,000-50,000), it is possible that  the loss of a small peptide 
may differentiate  these two forms. Although protease  inhibi- 
tors had no effect on the appearance of multiple forms of 
glycogen synthase kinase, it is possible that these were gen- 
erated by resistant  proteases or by a nonproteolytic mecha- 
nism. Since renal cortex contains  a heterogeneous population 
of cells, it is also possible that these forms originate from 
different cell types. These activities were determined using 
the conversion assay which  was used to  detect only kinases 
which inactivate glycogen synthase and have low K,,, values 
for this substrate. Consequently, the phosphorylation assay 
was required to detect the heparin-sensitive  phosvitin/casein 
kinase which phosphorylates but does not  inactivate glycogen 
synthase (18-21). 
We have previously reported on the partial purification of 
GSK-P from porcine renal cortex (23). Although those data 
suggested a homogeneous preparation with respect to kinase, 
subsequent purification demonstrated GSK-P  to be a heter- 
ogeneous group of  glycogen synthase kinases. These kinases 
were unresolvable by procedures previously utilized including 
successive salt  step elutions or gradient elution from phos- 
phocellulose, gradient  elution from CM-cellulose, DEAE-cel- 
lulose, or gel filtration. Only ATP gradient elution from AEP- 
agarose was capable of separating multiple forms of renal 
GSK-P. Much higher concentrations of sodium chloride or 
phosphate were required to elute glycogen synthase kinase 
activity from AEP-agarose and there was no separation of 
forms.3 When crude extracts were directly chromatographed 
on AEP-agarose, about 70% of the glycogen synthase kinase 
activity eluted at  the same position as GSK-A1.3 This suggests 
that GSK-A1 was not generated by the purification procedure. 
It is interesting that GSK-A1 and  the  other kinases compris- 
ing GSK-P readily bound to resins containing phosphate 
groups. GSK-P bound tightly to phosphocellulose but poorly 
to CM-cellulose. Since both sodium chloride and sodium 
citrate were required for elution, the behavior of these  kinases 
on hydroxyapatite suggests that they bound to  the calcium 
site as well as  to  the phosphate  site. 
The most remarkable feature of GSK-A1 is its specificity 
for glycogen synthase and ATP. In addition, GSK-A1 cata- 
lyzed phosphorylation of only one site at  or near  Ser-7 at  the 
NH, terminus of the molecule. Several separate pieces of 
evidence confirm this finding. Only 1 mol  of 32P/m~l  of 
subunit was incorporated into glycogen synthase. This phos- 
phate was located in  a M, = 10,000-12,000 CNBr peptide of 
glycogen synthase and in a trypsin-insensitive peptide of 
glycogen synthase. Glycogen synthase phosphorylated with 
GSK-A1 could not be further phosphorylated by phosphoryl- 
ase kinase. These observations are  consistent with GSK-A1 
catalyzing the phosphorylation of  glycogen synthase at  Ser-7 
(site 2) (21). High performance liquid chromatography, done 
in collaboration with Dr. Thomas R. Soderling, was a final 
piece of evidence demonstrating that GSK-A1 only catalyzed 
the phosphorylation of a site tentatively identified as  Ser-7 
(site 2). Although the only known phosphorylation site  near 
the NH, terminus of glycogen synthase is Ser-7, we have not 
ruled out at  this time that phosphorylation occurs at  another 
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site near  Ser-7  on glycogen synthase. This  substrate specific- 
ity for synthase but not phosphorylase or phosphorylase ki- 
nase suggests that GSK-A1 is also specific in its role in 
glycogenesis. In similar  studies GSK-A2 was found to evenly 
distribute  about 2 mol of 32P/m01 of synthase monomer into 
sites la, 2, and 3a, b, c . ~  It should be noted that these  studies 
used rabbit muscle glycogen synthase as substrate. It is not 
known if the phosphorylation of renal glycogen synthase 
would  be .identical. 
Phosphorylase  kinase (Zl), Ca2+-calmodulin-dependent gly- 
cogen synthase kinase (15-17), and GSK-4 (21) are other 
kinases which have been shown to catalyze the phosphoryla- 
tion of Ser-7 on glycogen synthase. Since GSK-A1 did not 
phosphorylate phosphorylase and was not stimulated by Ca2+- 
calmodulin or inhibited by EGTA or trifluoperazine, this 
kinase cannot be identified as phosphorylase kinase or the 
Caz+-calmodulin-dependent glycogen synthase kinase. GSK- 
A1 and GSK-4 (21) were similar  in that both were eluted from 
phosphocellulose at low ionic strength  and have low Michaelis 
constants  and  are specific for glycogen synthase and ATP. 
However, GSK-4 bound to DEAE-cellulose and was eluted 
with 0.2 M NaCI, while repeated attempts to use DEAE- 
cellulose to purify GSK-A1  indicated it would not  bind  under 
the most favorable conditions. In addition,  GSK-A1 was in- 
hibited 50% by 64 mM NaCl while GSK-4 was stimulated by 
a  similar NaCl concentration (21). Based on gel filtration, the 
apparent molecular weight was 45,000-50,000 for GSK-A1 
and 115,000 for GSK-4. Finally, GSK-A1 and  the  other ki- 
nases in GSK-P were not stable for extended periods of time 
in the  Tris buffers used to purify GSK-4. Thus, it is clear that 
major differences exist between GSK-A1 and GSK-4. 
The glycogen synthase activity  ratio  in  rabbit kidney cortex 
is  low (0.05 and  the A0.5 for glucose-6-P is high (2 mM) (23). 
These two phenomena can be explained by extensive phos- 
phorylation of cortical glycogen synthase in uiuo. Schlender 
and Reimann (22) demonstrated that 80-95%  of the glycogen 
synthase kinase activity in rat kidney was independent of 
CAMP. Also,  70-80% of the glycogen synthase kinase activity 
of rabbit  renal cortex or medulla was insensitive to  the  heat- 
stable  inhibitor of CAMP-dependent protein kinase (23). Men- 
dicino et al. (42) determined that the apparent K,,, of the 
CAMP-dependent protein kinase for glycogen synthase (50 
p ~ )  was about 1300 times the kidney glycogen synthase 
concentration. These  data suggest that  the CAMP-dependent 
protein  kinase  plays  a modest role in the inactivation of renal 
synthase. Since no Ca2+-calmodulin-stimulated glycogen syn- 
thase kinase activity could be  detected in renal  cortex  extracts 
(23), it also appears that Ca2+-calmodulin synthase kinase 
does not play an important role in producing the highly 
inactivated and phosphorylated glycogen synthase  in kidney 
cortex. Given the predominance of CAMP-independent gly- 
cogen synthase kinase in rabbit renal cortex (23, 24) and 
GSK-A1 in swine renal cortex, it is highly likely that this 
class of kinases  plays an important role in  the regulation of 
glycogen synthase in renal cortex. Although the regulatory 
mechanism of these kinases has not yet been determined, it 
is possible that control is afforded by known synthase effec- 
tors (UDP, UDP-glucose, ADP, and  Na2S04) (43) which 
caused some inhibition of GSK-A1 or by some as yet  unde- 
fined regulators. This regulation could occur by an allosteric 
modulation at  the level of the  substrate and/or kinase. 
It appears that more than one kinase participates in the 
inactivation of renal cortical glycogen synthase. GSK-A1 cat- 
alyzed the transfer of only 1 mol of 32P/mol of synthase 
subunit and reduced the activity ratio to about 0.5. GSK-A2 
catalyzed the transfer of a 2nd mol of 32P/mol of synthase 
subunit, but reduced the activity ratio to only 0.30. When 
both GSK-A1 and GSK-A2 were combined, synthase was 
phosphorylated and inactivated to  the same degree as with 
GSK-A2 alone. However, the  GSK-P preparation catalyzed 
the phosphorylation of at  least three sites and reduced the 
activity ratio to 50.10. This suggests that still another kinase, 
a kinase activator, or substrate modulator is present  in the 
GSK-P preparation. 
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